Usefulness of thrombosis and inflammation biomarkers in chronic thromboembolic pulmonary hypertension-sampling plasma and surgical specimens.

[1]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[2]  J. Barberà,et al.  Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry , 2016, Circulation.

[3]  Jose Luis Zamorano,et al.  The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS) , 2014 .

[4]  S. Miyata,et al.  Platelets Are Highly Activated in Patients of Chronic Thromboembolic Pulmonary Hypertension , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[5]  M. Madani,et al.  Update on chronic thromboembolic pulmonary hypertension. , 2014, Circulation.

[6]  W. Klepetko,et al.  Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy , 2013, Thorax.

[7]  J. Yuan,et al.  Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding , 2012, European Respiratory Journal.

[8]  A. Ogawa,et al.  Multipotent mesenchymal progenitor cells are present in endarterectomized tissues from patients with chronic thromboembolic pulmonary hypertension. , 2010, American journal of physiology. Cell physiology.

[9]  Susan C. Weber,et al.  STRIDE - An Integrated Standards-Based Translational Research Informatics Platform , 2009, AMIA.

[10]  T. Nawrot,et al.  C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. , 2009, Journal of the American College of Cardiology.

[11]  S. Sakao,et al.  Association of deep vein thrombosis type with clinical phenotype of chronic thromboembolic pulmonary hypertension. , 2009, International journal of cardiology.

[12]  W. Klepetko,et al.  Pulmonary Vascular Reactivity and Prognosis in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Pilot Study , 2009, Circulation.

[13]  H. Bergmeister,et al.  Role for Staphylococci in Misguided Thrombus Resolution of Chronic Thromboembolic Pulmonary Hypertension , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[14]  W. Klepetko,et al.  Predictors of Outcome in Chronic Thromboembolic Pulmonary Hypertension , 2007, Circulation.

[15]  Virgil L. Woods,et al.  Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. , 2006, American journal of respiratory and critical care medicine.

[16]  M. Schemper,et al.  Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension , 2005, Thrombosis and Haemostasis.

[17]  P. Corris,et al.  Interventional and surgical modalities of treatment for pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.

[18]  I. Lang.  Chronic thromboembolic pulmonary hypertension--not so rare after all. , 2004, The New England journal of medicine.

[19]  Mark B Pepys,et al.  C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.

[20]  P. Thistlethwaite,et al.  Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. , 2002, The Journal of thoracic and cardiovascular surgery.

[21]  M. Kramer,et al.  Significance of a plasma D-dimer test in patients with primary pulmonary hypertension. , 2002, Chest.

[22]  D. Rothenbacher,et al.  Plasma Fibrin D-Dimer Levels and Risk of Stable Coronary Artery Disease: Results of a Large Case-Control Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[23]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .